These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 12414341

  • 21. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology.
    Cazzaniga G, Biondi A.
    Haematologica; 2005 Mar; 90(3):382-90. PubMed ID: 15749670
    [Abstract] [Full Text] [Related]

  • 22. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
    Macintyre EA, d'Auriol L, Duparc N, Leverger G, Galibert F, Sigaux F.
    J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
    [Abstract] [Full Text] [Related]

  • 23. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
    Germano G, del Giudice L, Palatron S, Giarin E, Cazzaniga G, Biondi A, Basso G.
    Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
    [Abstract] [Full Text] [Related]

  • 24. The pattern of clonal immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Chinese adult acute lymphoblastic leukemia patients.
    Yao L, Chen Z, Cen J, Liang J, Feng Y, He J, Qi X, Shen H.
    Leuk Res; 2008 Nov; 32(11):1735-40. PubMed ID: 18456325
    [Abstract] [Full Text] [Related]

  • 25. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
    Miglino M, Berisso G, Grasso R, Canepa L, Clavio M, Pierri I, Pietrasanta D, Gatto S, Varaldo R, Ballerini F, Verdiani S, Casarino L, DeStefano F, Sessarego M, Dominietto A, Raiola AM, Bregante S, di Grazia C, Gobbi M, Bacigalupo A.
    Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia.
    Meleshko AN, Lipay NV, Stasevich IV, Potapnev MP.
    Exp Oncol; 2005 Dec; 27(4):319-24. PubMed ID: 16404354
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
    van der Velden VH, Wijkhuijs JM, Jacobs DC, van Wering ER, van Dongen JJ.
    Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
    [Abstract] [Full Text] [Related]

  • 30. Detection of minimal residual disease in peripheral blood prior to clinical relapse of childhood acute lymphoblastic leukaemia using PCR.
    Lal A, Kwan E, Haber M, Norris MD, Marshall GM.
    Mol Cell Probes; 2001 Apr; 15(2):99-103. PubMed ID: 11292328
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ, Gu LJ, Jiang LM, Zhao JC, Chen J, Pan C, Dong L, Chen J, Xue HL, Tang JY, Wang YP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
    [Abstract] [Full Text] [Related]

  • 33. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T, Yokota S, Nakao M, Misawa S, Takaue Y, Koizumi S, Kawai S, Fujimoto T.
    Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.
    Meleshko AN, Belevtsev MV, Savitskaja TV, Potapnev MP.
    Leuk Res; 2006 Jul; 30(7):795-800. PubMed ID: 16386788
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora KW, Holter W, Kabisch H, Klingebiel T, von Stackelberg A, ALL-REZ BFM Study Group.
    J Clin Oncol; 2009 Jan 20; 27(3):377-84. PubMed ID: 19064980
    [Abstract] [Full Text] [Related]

  • 39. Gamma and delta chain gene rearrangement of T cell receptor in acute lymphoblastic leukemia.
    Tong JH, Dong S, Chen Y, Qian ZZ, Gu LJ, Zhang YM, Wang ZY, Chen SJ, Chen Z.
    Chin Med J (Engl); 1994 Jan 20; 107(1):12-8. PubMed ID: 8187567
    [Abstract] [Full Text] [Related]

  • 40. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G, Barragán E, Bolufer P, Chillón C, García-Sanz R, Gómez T, Brunet S, González M, Sanz MA.
    Haematologica; 2000 Jul 20; 85(7):699-703. PubMed ID: 10897121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.